Medicine Description humira 40mg/0.8ml
humira 40mg/0.8ml prefilled syringe is a medication that contains adalimumab, a fully human monoclonal antibody designed to specifically target and inhibit tumor necrosis factor-alpha (TNF-α). TNF-α is a pro-inflammatory cytokine that plays a significant role in the inflammatory processes associated with autoimmune diseases. By binding to TNF-α, adalimumab prevents it from interacting with its receptors, thereby reducing inflammation, alleviating symptoms, and preventing further joint damage in conditions such as rheumatoid arthritis and inflammatory bowel disease.
Indications and Uses of humira 40mg/0.8ml prefilled syringe
- Rheumatoid arthritis in adults
- Juvenile idiopathic arthritis
- Psoriatic arthritis
- Ankylosing spondylitis
- Crohn's disease
- Ulcerative colitis
- Plaque psoriasis
- Hidradenitis suppurativa
- Uveitis
Side Effects of humira 40mg/0.8ml prefilled syringe
- Injection site reactions (redness, swelling, itching)
- Headache
- Increased risk of infections
- Nausea
- Rash
- Fatigue
- Abdominal pain
Storage and Handling
Store humira 40mg/0.8ml prefilled syringes in the refrigerator between 2°C and 8°C (36°F and 46°F). Do not freeze. Keep the medication in its original packaging to protect it from light until use. Allow the syringe to reach room temperature before injecting.
Patient Advice and Precautions
Before using humira, inform your healthcare provider of any allergies or medical conditions, particularly infections, or a history of tuberculosis. Regular monitoring for signs of infection is essential during treatment. Ensure proper injection techniques are followed to minimize side effects. Discuss potential vaccine interactions with your doctor, as live vaccines should generally be avoided during treatment.